"Vaccines, Synthetic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Small synthetic peptides that mimic surface antigens of pathogens and are immunogenic, or vaccines manufactured with the aid of recombinant DNA techniques. The latter vaccines may also be whole viruses whose nucleic acids have been modified.
| Descriptor ID |
D014614
|
| MeSH Number(s) |
D12.776.828.868 D20.215.894.865 D23.050.865
|
| Concept/Terms |
Vaccines, Synthetic- Vaccines, Synthetic
- Synthetic Vaccines
- Synthetic Immunogens
- Immunogens, Synthetic
Molecular Vaccines- Molecular Vaccines
- Vaccines, Molecular
- Vaccines, Chemical
- Chemical Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Vaccines, Synthetic".
Below are MeSH descriptors whose meaning is more specific than "Vaccines, Synthetic".
This graph shows the total number of publications written about "Vaccines, Synthetic" by people in this website by year, and whether "Vaccines, Synthetic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 7 | 3 | 10 |
| 1997 | 3 | 3 | 6 |
| 1998 | 4 | 2 | 6 |
| 1999 | 5 | 1 | 6 |
| 2000 | 1 | 4 | 5 |
| 2001 | 1 | 1 | 2 |
| 2002 | 2 | 4 | 6 |
| 2003 | 3 | 2 | 5 |
| 2004 | 2 | 5 | 7 |
| 2005 | 2 | 3 | 5 |
| 2006 | 2 | 2 | 4 |
| 2007 | 3 | 3 | 6 |
| 2008 | 1 | 4 | 5 |
| 2009 | 0 | 4 | 4 |
| 2010 | 2 | 3 | 5 |
| 2011 | 1 | 1 | 2 |
| 2012 | 1 | 7 | 8 |
| 2013 | 0 | 3 | 3 |
| 2014 | 2 | 4 | 6 |
| 2015 | 1 | 5 | 6 |
| 2016 | 0 | 7 | 7 |
| 2017 | 2 | 7 | 9 |
| 2018 | 2 | 2 | 4 |
| 2019 | 0 | 2 | 2 |
| 2020 | 1 | 6 | 7 |
| 2021 | 2 | 15 | 17 |
| 2022 | 1 | 18 | 19 |
| 2023 | 0 | 3 | 3 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 7 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vaccines, Synthetic" by people in Profiles.
-
Marburg virus glycoprotein mRNA vaccine is more protective than a virus-like particle-forming mRNA vaccine. J Clin Invest. 2025 Sep 02; 135(17).
-
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Nat Commun. 2025 Jul 01; 16(1):5702.
-
Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. Vaccine. 2025 Aug 13; 61:127361.
-
rVSV?G-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model. Viruses. 2025 02 28; 17(3).
-
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial. Clin Infect Dis. 2025 02 05; 80(1):223-227.
-
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost. Nat Commun. 2025 Jan 17; 16(1):759.
-
Altering the intracellular trafficking of Necator americanus GST-1 antigen yields novel hookworm mRNA vaccine candidates. PLoS Negl Trop Dis. 2025 Jan; 19(1):e0012809.
-
Determination of T cell response against XBB variants in adults who received either monovalent wild-type inactivated whole virus or mRNA vaccine or bivalent WT/BA.4-5 COVID-19 mRNA vaccine as the additional booster. Int J Infect Dis. 2024 Dec; 149:107271.
-
A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science. Mol Med. 2024 Mar 15; 30(1):37.
-
Broad protective vaccination against systemic Escherichia coli with autotransporter antigens. PLoS Pathog. 2023 02; 19(2):e1011082.